News T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Real-time Estimate Cboe BZX Other stock markets 03:12:51 2024-05-09 pm EDT			5-day change	1st Jan Change
3.265 ^USD	+7.05%		-8.22%	-46.61%

May. 07	T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease	CI
May. 07	North American Morning Briefing : Stock Futures Muted After Rally Fueled by Rate-Cut Hopes	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease	May. 07	AQ
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease	May. 07	CI
North American Morning Briefing : Stock Futures Muted After Rally Fueled by Rate-Cut Hopes	May. 07	DJ
T2 Biosystems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 06	CI
T2 Biosystems: Q1 Earnings Snapshot	May. 06	AQ
Earnings Flash (TTOO) T2 BIOSYSTEMS Posts Q1 Revenue $2.1M	May. 06	MT
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor	May. 06	AQ
T2 Biosystems Announces First Quarter 2024 Financial Results	May. 06	AQ
T2 Biosystems, Inc. Reiterates Revenue Guidance for the Full Year 2024	May. 06	CI
T2 Biosystems, Inc. Announces Commercial Expansion Through Middle East Distributor	May. 06	CI
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity	May. 06	AQ
Transcript : T2 Biosystems, Inc., Q1 2024 Earnings Call, May 06, 2024	May. 06
Canaccord Genuity Adjusts Price Target on T2 Biosystems to $3 From $12, Maintains Hold Rating	Apr. 29	MT
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024	Apr. 24	AQ
Top Premarket Decliners	Apr. 23	MT
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity	Apr. 11	AQ
T2 Biosystems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.	Mar. 28	AQ
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc	Mar. 28	CI
T2 Biosystems, Inc. Reiterates Revenue Guidance for the Year 2024	Mar. 20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Summary

Filters